Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time
Published
The U.S. National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine show that Gilead Sciences Inc's remdesivir is effective at helping COVID-19 patients recover.
Full Article